New Key Statistics Module, Z-Score and F-Score
SZSE:301408 Key Ratios
Market Cap ¥ M | 5,048.13 |
Enterprise Value ¥ M | 4,990.45 |
P/E(ttm) | 38.71 |
PE Ratio without NRI | 35.75 |
Forward PE Ratio | -- |
Price/Book | 2.53 |
Price/Sales | 1.25 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 4,055.00 |
EPS (TTM) ¥ | 0.33 |
Beneish M-Score | -1.59 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 45.10 |
y-y EBITDA Growth Rate % | -83.90 |
EV-to-EBIT | 25.45 |
EV-to-EBITDA | 25.45 |
PEG | 0.79 |
Shares Outstanding M | 400.01 |
Net Margin (%) | 3.28 |
Operating Margin % | 5.33 |
Pre-tax Margin (%) | 4.50 |
Quick Ratio | 0.96 |
Current Ratio | 1.38 |
ROA % (ttm) | 3.10 |
ROE % (ttm) | 6.93 |
ROIC % (ttm) | 8.00 |
Dividend Yield % | -- |
Altman Z-Score | 2.36 |
SZSE:301408 Number of Guru Trades
SZSE:301408 Volume of Guru Trades
Gurus Latest Trades with SZSE:301408
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301408 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Anhui Huaren Health Pharmaceutical Co Ltd Insider Transactions
No Available Data